Ep. 78 - Dr. John LaMattina on Balancing Innovation, Medicine, and Drug Prices

from The Economics Review · host Aadi Golchha

Dr. John LaMattina is the former President of Global Research and Development at Pfizer, overseeing the drug discovery and development efforts of over 13,000 colleagues across the world. He is now a Senior Partner and a member of the Board of Directors of PureTech Health. Holding a Ph.D. from the University of New Hampshire in Organic Chemistry, his latest book is titled Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices.

Episode metadata supplied by the publisher feed · Published Aug 20, 2022

Embed this episode

Attribution link and audio player

Ready to play

Ep. 78 - Dr. John LaMattina on Balancing Innovation, Medicine, and Drug Prices

0:00 32:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

5 Ways AARP Is Fighting to Lower Drug Prices

Mar 30, 2026 ·14m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Economics Review?

This episode is 32 minutes long.

When was this The Economics Review episode published?

This episode was published on August 20, 2022.

Can I download this The Economics Review episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!